CAA63356.1 |
p35 [Homo sapiens] |
35.0 |
623 |
10% |
0.005 | 80% | |
ABD59798.1 |
P2 nucleotide receptor 7 splice
variant J [Homo sapiens] |
28.6 |
295 |
5% |
0.44 | 100% | |
NP_056153.2 |
putative Polycomb group protein ASXL1
isoform 1 [Homo sapiens] |
26.9 |
1606 |
27% |
1.4 | 100% | |
NP_001690.2 |
tyrosine-protein kinase receptor UFO
isoform 2 [Homo sapiens] |
25.2 |
1051 |
17% |
4.6 | 100% | |
NP_006589.2 |
solute carrier family 12 member 7
[Homo sapiens] |
25.2 |
1418 |
23% |
4.6 | 100% | |
NP_068713.2 |
tyrosine-protein kinase receptor UFO
isoform 1 [Homo sapiens] |
25.2 |
1070 |
17% |
4.6 | 100% | |
AAD56722.1 |
autocrine motility factor receptor
[Homo sapiens] |
25.2 |
1070 |
17% |
4.6 | 100% | |
BAF35583.1 |
ubiquitin ligase [Homo sapiens] |
25.2 |
1494 |
23% |
4.6 | 100% | |
NP_002256.2 |
importin subunit beta-1 [Homo
sapiens] |
25.2 |
1045 |
15% |
4.6 | 100% | |
NP_612144.1 |
E3 ubiquitin-protein ligase DTX3L
[Homo sapiens] |
24.8 |
737 |
11% |
6.2 | 100% | |
NP_663314.1 |
programmed cell death protein 4
isoform 2 [Homo sapiens] |
24.4 |
504 |
8% |
8.3 | 100% | |
NP_055271.2 |
programmed cell death protein 4
isoform 1 [Homo sapiens] |
24.4 |
505 |
8% |
8.3 | 100% | |
NP_006366.2 |
ecto-NOX disulfide-thiol exchanger 2
isoform a [Homo sapiens] |
24.4 |
960 |
17% |
8.3 | 100% | |
NP_003784.2 |
cathepsin F precursor [Homo sapiens] |
24.4 |
548 |
9% |
8.3 | 100% | |
NP_872114.1 |
ecto-NOX disulfide-thiol exchanger 2
isoform b [Homo sapiens] |
24.4 |
1007 |
18% |
8.3 | 100% | |
NP_002630.2 |
serpin B5 [Homo sapiens] |
24.0 |
529 |
9% |
11 | 100% | |
NP_065866.1 |
protocadherin-10 isoform 2 precursor
[Homo sapiens] |
24.0 |
1438 |
21% |
11 | 100% | |
NP_001483.3 |
embryonic growth/differentiation
factor 1 precursor [Homo sapiens] |
24.0 |
579 |
9% |
11 | 100% | |
NP_795372.1 |
interferon epsilon precursor [Homo
sapiens] |
24.0 |
411 |
6% |
11 | 100% | |
AAA73090.1 |
unknown [Homo sapiens] |
24.0 |
520 |
9% |
11 | 100% | |
NP_116586.1 |
protocadherin-10 isoform 1 precursor
[Homo sapiens] |
24.0 |
1577 |
23% |
11 | 100% | |
NP_036363.2 |
PR domain zinc finger protein 2
isoform a [Homo sapiens] |
23.1 |
2268 |
32% |
11 | 100% | |
NP_056950.2 |
PR domain zinc finger protein 2
isoform b [Homo sapiens] |
23.1 |
2189 |
32% |
11 | 100% | |
NP_001007258.1 |
PR domain zinc finger protein 2
isoform c [Homo sapiens] |
23.1 |
1933 |
29% |
12 | 100% | |
NP_006540.3 |
calcium/calmodulin-dependent protein
kinase kinase 2 isoform 1 [Homo sapiens] |
23.5 |
802 |
12% |
15 | 100% | |
NP_000450.2 |
angiopoietin-1 receptor precursor
[Homo sapiens] |
23.5 |
1258 |
20% |
15 | 100% | |
AAN76689.1 |
cervical cancer oncogene binding
protein [Homo sapiens] |
23.5 |
307 |
4% |
15 | 100% | |
NP_000446.1 |
serine/threonine-protein kinase 11
[Homo sapiens] |
23.5 |
562 |
8% |
15 | 100% | |
NP_001245.1 |
cell division control protein 6
homolog [Homo sapiens] |
23.5 |
905 |
18% |
15 | 100% | |
Q9NYL2.2 |
RecName: Full=Mitogen-activated
protein kinase kinase kinase MLT; AltName: Full=MLK-like
mitogen-activated protein triple kinase; AltName: Full=Sterile alpha
motif- and leucine zipper-containing kinase AZK; AltName: Full=Leucine
zipper- and sterile alpha motif-containing kinase; AltName: Full=Mixed
lineage kinase-related kinase; Short=MLK-related kinase; Short=MRK;
AltName: Full=Human cervical cancer suppressor gene 4 protein;
Short=HCCS-4 |
23.5 |
1144 |
17% |
15 | 100% | |
NP_059105.2 |
homeobox protein Hox-C10 [Homo
sapiens] |
23.5 |
376 |
6% |
15 | 100% | |
NP_705719.2 |
calcium/calmodulin-dependent protein
kinase kinase 2 isoform 2 [Homo sapiens] >ref|NP_757380.1|
calcium/calmodulin-dependent protein kinase kinase 2 isoform 2 [Homo
sapiens] |
23.5 |
774 |
12% |
15 | 100% | |
NP_067645.3 |
zinc finger protein 350 [Homo
sapiens] |
23.1 |
394 |
8% |
20 | 100% | |
NP_001137.2 |
angiopoietin-1 precursor [Homo
sapiens] |
23.1 |
632 |
11% |
20 | 100% | |
NP_001139436.1 |
solute carrier family 12 member 4
isoform e [Homo sapiens] |
22.7 |
1544 |
28% |
27 | 100% | |
NP_001139435.1 |
solute carrier family 12 member 4
isoform d [Homo sapiens] |
22.7 |
1544 |
28% |
27 | 100% | |
NP_001139434.1 |
solute carrier family 12 member 4
isoform c [Homo sapiens] |
22.7 |
1564 |
28% |
27 | 100% | |
NP_001139433.1 |
solute carrier family 12 member 4
isoform b [Homo sapiens] |
22.7 |
1513 |
27% |
27 | 100% | |
NP_001129082.1 |
PR domain zinc finger protein 2
isoform d [Homo sapiens] |
22.7 |
299 |
5% |
27 | 100% | |
NP_857593.1 |
kunitz-type protease inhibitor 1
isoform 1 precursor [Homo sapiens] |
22.7 |
817 |
14% |
27 | 100% | |
NP_003701.1 |
kunitz-type protease inhibitor 1
isoform 2 precursor [Homo sapiens] >ref|NP_001027539.1| kunitz-type
protease inhibitor 1 isoform 2 precursor [Homo sapiens] |
22.7 |
801 |
13% |
27 | 100% | |
NP_001112359.1 |
angiopoietin-2 isoform b precursor
[Homo sapiens] |
22.7 |
1001 |
16% |
27 | 100% | |
NP_005063.1 |
solute carrier family 12 member 4
isoform a [Homo sapiens] |
22.7 |
1544 |
28% |
27 | 100% | |
NP_001138.1 |
angiopoietin-2 isoform a precursor
[Homo sapiens] |
22.7 |
984 |
16% |
27 | 100% | |
NP_001104516.1 |
cyclin-A1 isoform c [Homo sapiens]
>ref|NP_001104517.1| cyclin-A1 isoform c [Homo sapiens] |
22.3 |
640 |
10% |
36 | 100% | |
NP_079389.2 |
hypothetical protein LOC80183 [Homo
sapiens] |
22.3 |
867 |
15% |
36 | 100% | |
NP_001108451.1 |
tumor protein 63 isoform 3 [Homo
sapiens] |
22.3 |
787 |
14% |
36 | 100% | |
NP_003713.3 |
tumor protein 63 isoform 1 [Homo
sapiens] >sp|Q9H3D4.1|P63_HUMAN RecName: Full=Tumor protein 63;
Short=p63; AltName: Full=Transformation-related protein 63; Short=TP63;
AltName: Full=Tumor protein p73-like; Short=p73L; AltName: Full=p51;
AltName: Full=p40; AltName: Full=Keratinocyte transcription factor KET;
AltName: Full=Chronic ulcerative stomatitis protein; Short=CUSP |
22.3 |
1055 |
17% |
36 | 100% | |
NP_001104515.1 |
cyclin-A1 isoform b [Homo sapiens] |
22.3 |
716 |
11% |
36 | 100% | |
NP_006738.3 |
signal-induced
proliferation-associated protein 1 [Homo sapiens] >ref|NP_694985.29|
signal-induced proliferation-associated protein 1 [Homo sapiens] |
22.3 |
1056 |
16% |
36 | 100% | |
NP_002645.3 |
pyruvate kinase isozymes M1/M2
isoform M2 [Homo sapiens] |
22.3 |
578 |
10% |
36 | 100% | |
NP_003905.1 |
cyclin-A1 isoform a [Homo sapiens] |
22.3 |
688 |
11% |
36 | 100% | |
NP_004438.3 |
epidermal growth factor receptor
kinase substrate 8 [Homo sapiens] |
22.3 |
1086 |
17% |
36 | 100% | |
NP_003053.1 |
slit homolog 3 protein precursor
[Homo sapiens] |
21.8 |
2479 |
33% |
37 | 100% | |
NP_000219.2 |
laminin subunit beta-3 precursor
[Homo sapiens] >ref|NP_001017402.1| laminin subunit beta-3 precursor
[Homo sapiens] >ref|NP_001121113.1| laminin subunit beta-3 precursor
[Homo sapiens] |
21.8 |
1556 |
23% |
48 | 100% | |
NP_055213.2 |
lysosome-associated membrane
glycoprotein 3 [Homo sapiens] |
21.8 |
504 |
9% |
48 | 100% | |
1GUX_B |
Chain B, Rb Pocket Bound To E7 Lxcxe
Motif |
21.8 |
263 |
5% |
48 | 80% | |
1C4Z_A |
Chain A, Structure Of E6ap: Insights
Into Ubiquitination Pathway >pdb|1C4Z|B Chain B, Structure Of E6ap:
Insights Into Ubiquitination Pathway >pdb|1C4Z|C Chain C, Structure
Of E6ap: Insights Into Ubiquitination Pathway >pdb|1D5F|A Chain A,
Structure Of An E6ap-Ubch7 Complex: Insights Into The Ubiquitination
Pathway >pdb|1D5F|B Chain B, Structure Of An E6ap-Ubch7 Complex:
Insights Into The Ubiquitination Pathway >pdb|1D5F|C Chain C,
Structure Of An E6ap-Ubch7 Complex: Insights Into The Ubiquitination
Pathway |
21.8 |
384 |
7% |
48 | 100% | |
NP_113667.1 |
inhibin beta E chain precursor [Homo
sapiens] |
21.8 |
574 |
8% |
48 | 100% | |
BAG37574.1 |
unnamed protein product [Homo
sapiens] |
21.4 |
428 |
8% |
65 | 83% | |
NP_110394.3 |
AT-hook-containing transcription
factor [Homo sapiens] |
21.4 |
1715 |
25% |
65 | 100% | |
NP_787063.1 |
DNA (cytosine-5)-methyltransferase
3-like isoform 2 [Homo sapiens] |
21.4 |
592 |
10% |
65 | 100% | |
AAK34885.1 |
cervical cancer 1 protooncogene
protein p40 [Homo sapiens] |
21.4 |
430 |
8% |
65 | 83% | |
NP_932172.1 |
myeloid zinc finger 1 isoform 2 [Homo
sapiens] >ref|NP_003413.2| myeloid zinc finger 1 isoform 1 [Homo
sapiens] |
21.4 |
838 |
10% |
65 | 100% | |
NP_001019839.1 |
LETM1 domain-containing protein 1
isoform 2 [Homo sapiens] >gb|AAL26878.1|AF315598_1 cervical cancer
protooncogene-2 protein [Homo sapiens] |
21.4 |
396 |
7% |
65 | 100% | |
NP_056231.3 |
LETM1 domain-containing protein 1
isoform 1 [Homo sapiens] >sp|Q6P1Q0.1|LTMD1_HUMAN RecName: Full=LETM1
domain-containing protein 1; AltName: Full=Cervical cancer 1
proto-oncogene protein p40; AltName: Full=Cervical cancer proto-oncogene
2 protein; AltName: Full=HCRR-2 |
21.4 |
428 |
8% |
65 | 100% | |
NP_001112360.1 |
angiopoietin-2 isoform c precursor
[Homo sapiens] |
21.4 |
931 |
15% |
65 | 100% | |
NP_055167.2 |
POU domain, class 2, transcription
factor 3 [Homo sapiens] |
21.4 |
447 |
6% |
65 | 100% | |
NP_006345.1 |
transcriptional adapter 3 isoform a
[Homo sapiens] |
21.4 |
559 |
8% |
65 | 100% | |
NP_001116868.1 |
C-C chemokine receptor type 2 isoform
B [Homo sapiens] |
21.4 |
797 |
11% |
65 | 100% | |
AAO15677.1 |
cervical cancer oncogene 10 protein
[Homo sapiens] |
21.4 |
137 |
1% |
65 | 100% | |
P22607.1 |
RecName: Full=Fibroblast growth
factor receptor 3; Short=FGFR-3; AltName: CD_antigen=CD333; Flags:
Precursor |
21.4 |
973 |
17% |
65 | 100% | |
NP_597814.1 |
transcriptional adapter 3 isoform b
[Homo sapiens] |
21.4 |
453 |
6% |
65 | 100% | |
AAM46114.1 |
cervical cancer proto-oncogene 7
[Homo sapiens] |
21.4 |
806 |
12% |
65 | 100% | |
NP_037501.2 |
DNA (cytosine-5)-methyltransferase
3-like isoform 1 [Homo sapiens] |
21.4 |
609 |
11% |
65 | 100% | |
NP_005514.1 |
homeobox protein Hox-A11 [Homo
sapiens] |
21.4 |
402 |
5% |
65 | 100% | |
NP_001136403.1 |
apoptosis inhibitor 5 isoform c [Homo
sapiens] |
21.0 |
608 |
9% |
87 | 100% | |
NP_001136402.1 |
apoptosis inhibitor 5 isoform a [Homo
sapiens] |
21.0 |
675 |
10% |
87 | 100% | |
AAK56392.1 |
cervical cancer proto-oncogene 5
[Homo sapiens] |
21.0 |
787 |
11% |
87 | 100% | |
NP_001108454.1 |
tumor protein 63 isoform 6 [Homo
sapiens] |
21.0 |
597 |
10% |
87 | 100% | |
NP_001108453.1 |
tumor protein 63 isoform 5 [Homo
sapiens] |
21.0 |
672 |
11% |
87 | 100% | |
NP_001108452.1 |
tumor protein 63 isoform 4 [Homo
sapiens] |
21.0 |
865 |
14% |
87 | 100% | |
NP_056269.1 |
la-related protein 7 [Homo sapiens]
>ref|NP_057732.2| la-related protein 7 [Homo sapiens] |
21.0 |
544 |
8% |
87 | 100% | |
Q9BZZ5.2 |
RecName: Full=Apoptosis inhibitor 5;
Short=API-5; AltName: Full=Fibroblast growth factor 2-interacting
factor; Short=FIF; AltName: Full=Protein XAGL; AltName:
Full=Antiapoptosis clone 11 protein; Short=AAC-11; AltName: Full=Cell
migration-inducing gene 8 protein |
21.0 |
675 |
10% |
87 | 100% | |
NP_006586.1 |
apoptosis inhibitor 5 isoform b [Homo
sapiens] |
21.0 |
659 |
10% |
87 | 100% | |
NP_006784.1 |
thioredoxin-dependent peroxide
reductase, mitochondrial isoform a precursor [Homo sapiens] |
20.6 |
276 |
5% |
110 | 100% | |
NP_054817.2 |
thioredoxin-dependent peroxide
reductase, mitochondrial isoform b [Homo sapiens] |
20.6 |
242 |
4% |
113 | 100% | |
AAP85625.1 |
cervical cancer 1 protooncogene [Homo
sapiens] |
20.6 |
198 |
3% |
117 | 83% | |
AAL33003.2 |
cervical cancer 1
proto-oncogene-binding protein KG19 [Homo sapiens] |
20.6 |
303 |
5% |
117 | 100% | |
CAB43387.2 |
hypothetical protein [Homo sapiens] |
20.6 |
165 |
2% |
117 | 83% | |
NP_057334.1 |
protein NDRG2 isoform b [Homo
sapiens] >ref|NP_963294.1| protein NDRG2 isoform b [Homo sapiens]
>ref|NP_963832.1| protein NDRG2 isoform b [Homo sapiens]
>ref|NP_963835.1| protein NDRG2 isoform b [Homo sapiens] |
20.6 |
427 |
7% |
117 | 100% | |
Q9Y543.1 |
RecName: Full=Transcription factor
HES-2; AltName: Full=Hairy and enhancer of split 2; AltName: Full=Class B
basic helix-loop-helix protein 40; Short=bHLHb40 |
20.6 |
295 |
5% |
117 | 83% | |
AAN51931.1 |
cervical cancer oncogene 3 [Homo
sapiens] |
20.6 |
281 |
4% |
117 | 83% | |
NP_149040.3 |
thymic stromal cotransporter homolog
[Homo sapiens] |
20.6 |
656 |
11% |
117 | 100% | |
NP_963293.1 |
protein NDRG2 isoform a [Homo
sapiens] >ref|NP_963831.1| protein NDRG2 isoform a [Homo sapiens]
>ref|NP_963833.1| protein NDRG2 isoform a [Homo sapiens]
>ref|NP_963834.1| protein NDRG2 isoform a [Homo sapiens] |
20.6 |
427 |
7% |
117 | 100% | |
ACI25374.1 |
immunoglobulin M heavy chain constant
region [Homo sapiens] |
20.2 |
209 |
3% |
157 | 80% | |
NP_872270.1 |
pyruvate kinase isozymes M1/M2
isoform M1 [Homo sapiens] >ref|NP_872271.1| pyruvate kinase isozymes
M1/M2 isoform M1 [Homo sapiens] |
20.2 |
651 |
11% |
157 | 100% | |
NP_001020605.1 |
NAD(P)H dehydrogenase [quinone] 1
isoform c [Homo sapiens] |
20.2 |
280 |
4% |
157 | 100% | |
NP_001032720.1 |
cytotoxic T-lymphocyte protein 4
isoform b precursor [Homo sapiens] |
20.2 |
128 |
2% |
157 | 100% | |
AAO33376.1 |
cervical cancer suppressor gene-4
protein [Homo sapiens] |
20.2 |
333 |
4% |
157 | 83% | |
NP_659205.1 |
testisin isoform 2 [Homo sapiens] |
20.2 |
408 |
6% |
157 | 100% | |
NP_006790.1 |
testisin isoform 1 [Homo sapiens] |
20.2 |
408 |
6% |
157 | 100% | |
1GUX_A |
Chain A, Rb Pocket Bound To E7 Lxcxe
Motif |
20.2 |
274 |
4% |
157 | 100% | |
NP_659206.1 |
testisin isoform 3 [Homo sapiens] |
20.2 |
422 |
6% |
157 | 100% | |
NP_006513.1 |
protein Wnt-6 precursor [Homo
sapiens] |
20.2 |
389 |
6% |
157 | 100% | |
NP_006689.1 |
bladder cancer-associated protein
[Homo sapiens] >ref|NP_001161292.1| bladder cancer-associated protein
[Homo sapiens] >ref|NP_001161293.1| bladder cancer-associated
protein [Homo sapiens] >ref|NP_001161294.1| bladder cancer-associated
protein [Homo sapiens] >ref|NP_001161295.1| bladder
cancer-associated protein [Homo sapiens] >sp|P62952.1|BLCAP_HUMAN
RecName: Full=Bladder cancer-associated protein; AltName: Full=Bladder
cancer 10 kDa protein; Short=Bc10 |
20.2 |
264 |
4% |
157 | 100% | |
NP_005683.2 |
ATP-binding cassette sub-family F
member 2 isoform b [Homo sapiens] |
20.2 |
652 |
12% |
157 | 100% | |
NP_009120.1 |
ATP-binding cassette sub-family F
member 2 isoform a [Homo sapiens] |
20.2 |
619 |
11% |
157 | 100% | |
NP_001159970.1 |
heparanase isoform 2 precursor [Homo
sapiens] |
19.7 |
722 |
12% |
211 | 100% | |
AAM73658.1 |
cervical cancer suppressor gene 5
[Homo sapiens] |
19.7 |
117 |
2% |
211 | 80% | |
AAN51932.1 |
cervical cancer suppressor 3 [Homo
sapiens] |
19.7 |
267 |
5% |
211 | 100% | |
NP_703152.1 |
oral cancer overexpressed 1 [Homo
sapiens] |
19.7 |
160 |
2% |
211 | 83% | |
NP_004576.2 |
retinoic acid receptor responder
protein 3 [Homo sapiens] |
19.7 |
197 |
3% |
211 | 100% | |
NP_002965.1 |
serpin B4 [Homo sapiens] |
19.7 |
716 |
11% |
211 | 100% | |
NP_004995.1 |
NADH dehydrogenase [ubiquinone] 1
beta subcomplex subunit 8, mitochondrial precursor [Homo sapiens] |
19.7 |
165 |
2% |
211 | 100% | |
AAN32795.1 |
cervical cancer homeoprotein 103
[Homo sapiens] |
19.3 |
49.4 |
0% |
283 | 100% | |
AAK97314.1 |
cervical cancer proto-oncogene 2
[Homo sapiens] |
19.3 |
174 |
2% |
283 | 100% | |
Q9NX65.2 |
RecName: Full=Zinc finger protein
434; AltName: Full=Human cervical cancer suppressor gene 5 protein;
Short=HCCS-5 |
19.3 |
533 |
9% |
283 | 100% | |
NP_057251.2 |
nucleolar protein 7 [Homo sapiens]
>sp|Q9UMY1.2|NOL7_HUMAN RecName: Full=Nucleolar protein 7; AltName:
Full=Nucleolar protein of 27 kDa |
19.3 |
196 |
3% |
283 | 83% | |
NP_067091.1 |
interferon alpha-17 precursor [Homo
sapiens] |
19.3 |
241 |
4% |
283 | 100% | |
O14965.2 |
RecName:
Full=Serine/threonine-protein kinase 6; AltName: Full=Aurora kinase A;
AltName: Full=Serine/threonine-protein kinase aurora-A; AltName:
Full=Serine/threonine-protein kinase 15; AltName:
Full=Aurora/IPL1-related kinase 1; Short=Aurora-related kinase 1;
Short=ARK-1; Short=hARK1; AltName: Full=Breast tumor-amplified kinase |
19.3 |
564 |
8% |
283 | 100% | |
3F81_A |
Chain A, Interaction Of Vhr With Sa3
>pdb|3F81|B Chain B, Interaction Of Vhr With Sa3 |
18.9 |
216 |
4% |
379 | 100% | |
NP_001157882.1 |
cell division protein kinase 5
isoform 2 [Homo sapiens] |
18.9 |
347 |
6% |
379 | 100% | |
AAR97620.1 |
env [Homo sapiens] |
18.9 |
65.8 |
0% |
379 | 83% | |
AAN32794.1 |
cervical cancer homeoprotein 92 [Homo
sapiens] |
18.9 |
53.2 |
1% |
379 | 80% | |
ABM66091.1 |
FHIT [Homo sapiens]
>gb|ABM66092.1| FHIT [Homo sapiens] |
18.9 |
67.5 |
1% |
379 | 80% | |
NP_004206.1 |
receptor-binding cancer antigen
expressed on SiSo cells [Homo sapiens] >ref|NP_936056.1|
receptor-binding cancer antigen expressed on SiSo cells [Homo sapiens] |
18.9 |
219 |
3% |
379 | 100% | |
AAL61545.1 |
cervical cancer oncogene 9 [Homo
sapiens] |
18.9 |
180 |
2% |
379 | 100% | |
NP_004926.1 |
cell division protein kinase 5
isoform 1 [Homo sapiens] |
18.9 |
433 |
8% |
379 | 100% | |
1C4Z_D |
Chain D, Structure Of E6ap: Insights
Into Ubiquitination Pathway |
18.5 |
199 |
3% |
394 | 80% | |
NP_001093138.1 |
HIG1 domain family member 1A isoform a
[Homo sapiens] |
18.5 |
96.3 |
1% |
509 | 100% | |
NP_004584.1 |
transformer-2 protein homolog beta
[Homo sapiens] |
18.5 |
303 |
4% |
509 | 100% | |
NP_054775.2 |
HIG1 domain family member 1A isoform b
[Homo sapiens] >ref|NP_001093139.1| HIG1 domain family member 1A
isoform b [Homo sapiens] >sp|Q9Y241.1|HIG1A_HUMAN RecName: Full=HIG1
domain family member 1A; AltName: Full=Hypoxia-inducible gene 1 protein
>gb|AAD33954.1|AF145385_1 hypoxia-inducbile gene 1 [Homo sapiens] |
18.5 |
63.2 |
0% |
509 | 100% | |
NP_001094349.1 |
suppressor of tumorigenicity 20
protein [Homo sapiens] >ref|NP_001094350.1| suppressor of
tumorigenicity 20 protein [Homo sapiens] >sp|Q9HBF5.2|ST20_HUMAN
RecName: Full=Suppressor of tumorigenicity 20 protein; AltName:
Full=Human cervical cancer suppressor gene 1 protein; Short=HCCS-1 |
18.0 |
122 |
2% |
683 | 100% | |
AAG17280.1 |
cervical cancer suppressor-1 [Homo
sapiens] |
18.0 |
122 |
2% |
683 | 100% | |
ABM66086.1 |
FHIT [Homo sapiens]
>gb|ABM66088.1| FHIT [Homo sapiens] >gb|ABM66090.1| FHIT [Homo
sapiens] |
17.6 |
17.6 |
0% |
916 | 80% | |
ABM66087.1 |
truncated FHIT [Homo sapiens] |
17.6 |
17.6 |
0% |
916 | 80% | |
ABM66093.1 |
FHIT [Homo sapiens] |
17.6 |
49.8 |
0% |
916 | 71% | |
NP_001158075.1 |
putative Polycomb group protein ASXL1
isoform 2 [Homo sapiens] |
17.6 |
48.6 |
0% |
916 | 80% | |
AAM00228.1 |
cervical cancer oncogene 4 [Homo
sapiens] >gb|AAX93094.1| unknown [Homo sapiens] |
17.6 |
31.8 |
0% |
916 | 100% | |
AAP85624.1 |
cervical cancer 1 protooncogene [Homo
sapiens] |
16.3 |
47.7 |
1% |
2213 | 71% | |
AAK97637.1 |
T-cell receptor VB3 CDR3 region [Homo
sapiens] |
16.3 |
16.3 |
0% |
2213 | 66% | |
NP_037464.1 |
hypoxia-inducible gene 2 protein
[Homo sapiens] >ref|NP_001092256.1| hypoxia-inducible gene 2 protein
[Homo sapiens] >sp|Q9Y5L2.1|HIG2_HUMAN RecName:
Full=Hypoxia-inducible gene 2 protein >gb|AAD37585.1|AF144755_1
hypoxia-inducible protein 2 [Homo sapiens] |
16.3 |
64.1 |
0% |
2213 | 80% | |
AAF67076.1 |
T-cell receptor beta-chain, VB 16
[Homo sapiens] |
15.9 |
31.4 |
0% |
2970 | 80% | |
AAF67079.1 |
T-cell receptor alpha-chain, VA 10
[Homo sapiens] |
15.1 |
15.1 |
0% |
5347 | 62% | |
AAF67078.1 |
T-cell receptor alpha chain, VA 22
[Homo sapiens] |
14.2 |
14.2 |
0% |
9627 | 57% | |